Guy Mastrion, an entrepreneur and creative industry veteran with more than 30 years of experience in brand development, digital strategy, advertising, design, photography, and film for global brands, was appointed the ninth F. William Harder Chair of Business at Skidmore College.
Healthcare communications agency Calcium hired Damon Tutulic as senior VP, management director.
Dr. Craig Landau was appointed president and CEO of Purdue Pharma LP, the U.S. operations of Purdue Pharma headquartered in Stamford, Conn. He retains responsibility for Purdue Pharma (Canada).
Chris Posner was appointed the executive VP Region US and president and CEO of LEO Pharma Inc. On July 15, 2017, he became responsible for the U.S. business of LEO Pharma, a global healthcare company dedicated to helping people achieve healthy skin.
Vivek Kundra, the first chief information officer for the United States under President Obama, is the new chief operating officer of Outcome Health.
Myovant Sciences made four key appointments to its managing team. Matthew Lang, J.D., joined the company as general counsel and corporate secretary; Juan Camilo Arjona Ferreira, M.D., came aboard as chief medical officer; Teresa Perney, Ph.D., was appointed senior VP of Regulatory Affairs and Quality Assurance; and Andria Langenberg, M.D., was tapped as head of Drug Safety and Pharmacovigilance.
Arthur J. Shannon joined Valeant Pharmaceuticals International as senior VP, head of Investor Relations and Communications.
Jacob Licht has become chief operating officer of VLP Therapeutics. Licht joined VLP Therapeutics after 10 years at Emergent BioSolutions, where he most recently served as VP, Corporate Development.
Jeffrey A. Meckler was appointed CEO of Intec Pharma Ltd. Meckler was named vice chairman of the Intec Pharma board of directors in April 2017 and continues in that role.